Orchestra BioMed Holdings, Inc. (OBIO) Revenue History
Orchestra BioMed Holdings, Inc. (OBIO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $3.53M |
| 2023-12-31 | $2.76M |
| 2024-12-31 | $2.64M |
| 2025-12-31 | $33.48M |
How OBIO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NERV | — | $41.18M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
| ALEC | Alector Inc. | $21.05M |
| NMTC | NeuroOne Medical Technologies Corporation | $9.10M |
| ACRS | Aclaris Therapeutics Inc. | $7.83M |
These are five companies in the same sector as OBIO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Orchestra BioMed Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("OBIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | OBIO | $5.18 | +1.47% | 0.15M |
| 3 | ||||
| 4 | ||||
| 5 |